Doxy-PEP: Doxycycline for the Prevention of STIs

This presentation will describe the results of clinical trials evaluating the use of doxycycline as post-exposure prophylaxis to prevent STIs. It will identify patient populations where doxy-PEP was found to be effective for the prevention of STIs, and will review current recommendations regarding the use of doxy-PEP in the United States.